Zeria Pharmaceutical Co., Ltd. Sustainability Profile
Zeria Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in Japan. Founded in 1923, the company has established a strong presence in various operational regions, focusing on the development and manufacturing of innovative healthcare solutions. Zeria is renowned for its expertise in prescription pharmaceuticals, particularly in the fields of gastrointestinal and infectious diseases. With a commitment to research and development, Zeria has achieved significant milestones, including the introduction of unique formulations that address unmet medical needs. The company’s core products are distinguished by their efficacy and safety profiles, positioning Zeria as a trusted name in the healthcare sector. Notably, Zeria Pharmaceutical has garnered recognition for its contributions to patient care, solidifying its market position as a leader in Japan and beyond.
DitchCarbon Score
How does Zeria Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zeria Pharmaceutical Co., Ltd.'s score of 16 is lower than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zeria Pharmaceutical Co., Ltd.'s reported carbon emissions
Zeria Pharmaceutical Co., Ltd., headquartered in Japan, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company. As a result, Zeria Pharmaceutical's climate commitments and initiatives remain unclear. The company does not appear to inherit any emissions data from a parent or related organization, indicating that it operates independently in this regard. In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific data or commitments from Zeria Pharmaceutical, it is challenging to assess their position in this evolving landscape.
How Carbon Intensive is Zeria Pharmaceutical Co., Ltd.'s Industry?
How Carbon Intensive is Zeria Pharmaceutical Co., Ltd.'s Location?
Zeria Pharmaceutical Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Zeria Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
